Statins lower the risk of the most common type of stroke — caused by blocked arteries — by about one-fifth, no matter how low or high a person’s overall heart disease risk is.
Scientific Claim
Statin therapy reduces the risk of ischaemic stroke by 21% per 1.0 mmol/L LDL cholesterol reduction, with no evidence that the effect varies by baseline vascular risk.
Original Statement
“The proportional reductions in ischaemic stroke (RR per 1.0 mmol/L LDL cholesterol reduction 0.79, 95% CI 0.74–0.85) were similar irrespective of baseline major vascular event risk...”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The RCT-based meta-analysis provides high-quality evidence for a causal effect on ischaemic stroke, with consistent effect across strata and no heterogeneity.
Evidence from Studies
Supporting (1)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
This big study found that taking statins to lower cholesterol reduces stroke risk by about the same amount—whether you’re at low or high risk for heart problems to begin with.